CONTACT US

Investor Marketing Case Study: Helicon Group

About the Client: Helicon Group is an ASX listed healthcare / biotechnology group, its primary business model is to provide licensing services and distribute western biotechnology and pharmaceutical products into Greater Chinese Markets.

Requirements: At the client briefing, there are several areas identified as key objectives – the first objective is to promote the company to a wide range of investors, and the second objective is to promote the company to biotechnology & pharmaceutical companies to engage their services with Helicon, and also market Helicon in the Chinese markets.

Our Services:

We have provided a wide range of services to Helicon Group over the past 2 years:

• Development of Chinese Website – development of Helicon’s Chinese websites both in simplified and traditional Chinese.

• Chinese version Investment Report - we have also issued research reports and investment summary for Helicon Group and distribute them to investors.

• Regular Press Releases – We have also written and distributed press releases – both in English & Chinese and send them to investors and institutions.

• Management Interviews – Conducted a number of management interviews with its CEO and Chairman.

• Industry Target Marketing - Provide target marketing for Helicon to promote the company to biotech and healthcare professionals in Asia and Europe.

Helicon Group is one of our first clients in the healthcare & biotechnology sector, we have found this sector particularly biotechnology, health supplements and medical devices are all looking to explore new opportunities into Asian markets.